MRK Stock: The Grand Daddy of Pharma

The pharma legend is a good bet for income investors. Right now, Merck (NYSE: MRK), this nation’s second biggest pharmaceutical maker, is a curious animal: a value stock that’s… Read more

An Easy Way To Get The Details On A New IPO

This is my third article in a series on IPO investing. The goal of these articles is to arm you with a few basic tools to wade into new… Read more

Top 3 Dividends In This Emerging Market

Brazil, despite its somewhat sluggish economy, has been a big winner in the stock market. The iShares MSCI Brazil Index is up nearly 29% over the last six month…. Read more

Put Your “Best Effort” Into IPO Investing

We’re talking about IPO investing again today to add to the list of tips published in Monday’s issue of Daily Profit. IPO investing is a risky game that requires… Read more

Winners and Losers from Last Week’s IPO Offerings

It wasn’t quite the record windfall it was shaping up to be. But with 15 companies going public, last week was a busy week for IPO offerings. July closed… Read more

Should You Invest in BCX4430, the Miracle Ebola Drug?

I recently told you about a company that is working on a miracle Ebola drug, one that could help prevent future outbreaks of the deadly virus sweeping West Africa…. Read more

Can This Stock Stop the Ebola Outbreak?

I grew up in Reston, Virginia. Unless you’re from the Washington D.C. area I doubt you’ve ever heard of it. But my hometown almost became the epicenter of a… Read more

The 5 Big Earnings Reports of Last Week

Last week was a big week for corporate earnings reports. With stocks dropping after disappointing and popping after wowing, it was certainly exciting to watch the news come in. Big earnings… Read more

Beware Excessive Cash-Outs When IPO Investing

It is never a good idea to invest on hunches, rumors and hot tips. Similarly, it’s too risky to go all-in on stocks that just gained listing via an… Read more

To top